Omar F AbouEzzeddine
Overview
Explore the profile of Omar F AbouEzzeddine including associated specialties, affiliations and a list of published articles.
Author names and details appear as published. Due to indexing inconsistencies, multiple individuals may share a name, and a single author may have variations. MedLuna displays this data as publicly available, without modification or verification
Snapshot
Snapshot
Articles
46
Citations
974
Followers
0
Related Specialties
Related Specialties
Top 10 Co-Authors
Top 10 Co-Authors
Published In
Affiliations
Affiliations
Soon will be listed here.
Recent Articles
1.
De Michieli L, AbouEzzeddine O, Abbasi M, Davies D, Scott C, Muchtar E, et al.
JACC CardioOncol
. 2025 Feb;
7(1):70-78.
PMID: 39896120
Background: Technetium Tc 99m pyrophosphate scintigraphy (Tc PYP imaging) is a diagnostic tool for transthyretin amyloid cardiomyopathy (ATTR-CM). Cardiac biomarkers, particularly high-sensitivity cardiac troponin (hs-cTn) and N-terminal pro-B-type natriuretic peptide...
2.
Lyle M, Farina J, Wiedmeier-Nutor E, Lindpere V, Klanderman M, Nativi-Nicolau J, et al.
Clin Transplant
. 2025 Jan;
39(1):e70070.
PMID: 39775986
Background: The prognosis in patients with advanced cardiac amyloidosis (CA) remains poor. Objectives: We sought to describe survival post heart transplantation (HT) in amyloid compared with non-amyloid recipients, highlight waitlist...
3.
Fazzini L, Castrichini M, Bois M, Natt N, Chang I, Grogan M, et al.
Mayo Clin Proc
. 2024 Dec;
99(12):2008-2011.
PMID: 39631992
No abstract available.
4.
Tersalvi G, Vicenzi M, AbouEzzeddine O
JACC Adv
. 2024 Jun;
3(6):100971.
PMID: 38938868
No abstract available.
5.
Ingraham B, AbouEzzeddine O, Eleid M, Reddy Y
Circ Heart Fail
. 2023 Jul;
16(8):e010735.
PMID: 37492944
No abstract available.
6.
Gonzalez-Lopez E, Escobar-Lopez L, Obici L, Saturi G, Bezard M, Saith S, et al.
JACC CardioOncol
. 2022 Nov;
4(4):442-454.
PMID: 36444226
Background: Transthyretin amyloid cardiomyopathy (ATTR-CM) is increasingly recognized as a treatable cause of heart failure (HF). Advances in diagnosis and therapy have increased the number of patients diagnosed at early...
7.
Davies D, Redfield M, Scott C, Minamisawa M, Grogan M, Dispenzieri A, et al.
JAMA Cardiol
. 2022 Sep;
7(10):1036-1044.
PMID: 36069809
Importance: Transthyretin amyloid cardiomyopathy (ATTR-CM) is a form of heart failure (HF) with preserved ejection fraction (HFpEF). Technetium Tc 99m pyrophosphate scintigraphy (PYP) enables ATTR-CM diagnosis. It is unclear which...
8.
Shabtaie S, Sehrawat O, Lee J, Cha Y, Mulpuru S, Kowlgi N, et al.
J Cardiovasc Electrophysiol
. 2022 Jul;
33(9):2072-2080.
PMID: 35870183
Introduction: Cardiac sarcoidosis (CS) is a nonischemic cardiomyopathy (NICM) characterized by infiltration of noncaseating granulomas involving the heart with highly variable clinical manifestations that can include conduction abnormalities and systolic...
9.
Prevalence of Transthyretin Amyloid Cardiomyopathy in Heart Failure With Preserved Ejection Fraction
AbouEzzeddine O, Davies D, Scott C, Fayyaz A, Askew J, McKie P, et al.
JAMA Cardiol
. 2021 Aug;
6(11):1267-1274.
PMID: 34431962
Importance: Heart failure (HF) with preserved ejection fraction (HFpEF) is common, is frequently associated with ventricular wall thickening, and has no effective therapy. Transthyretin amyloid cardiomyopathy (ATTR-CM) can cause the...
10.
Elwazir M, Krause M, Bois J, Christopoulos G, Kendi A, Cooper J, et al.
J Card Fail
. 2021 Jul;
28(2):247-258.
PMID: 34320381
Background: We sought to examine the effect of anti-B-cell therapy (rituximab) on cardiac inflammation and function in corticosteroid-refractory cardiac sarcoidosis. Cardiac sarcoidosis (CS) is a rare cause of cardiomyopathy characterized...